Featured Research

from universities, journals, and other organizations

New technique uses zebrafish behavior to screen for useful compounds: Pathways affecting sleep and wakefulness discovered

Date:
January 15, 2010
Source:
Harvard University
Summary:
A robust new technique for screening drugs' effects on zebrafish behavior is pointing scientists toward unexpected compounds and pathways that may govern sleep and wakefulness in humans. Among their more intriguing findings: Various anti-inflammatory agents in the immune system, long known to induce sleep during infection, may also shape normal sleep/wake cycles.

Zebrafish. A robust new technique for screening drugs' effects on zebrafish behavior is pointing Harvard University scientists toward unexpected compounds and pathways that may govern sleep and wakefulness in humans.
Credit: File photograph by Justin Ide/Harvard Staff Photographer

A robust new technique for screening drugs' effects on zebrafish behavior is pointing Harvard University scientists toward unexpected compounds and pathways that may govern sleep and wakefulness in humans.

Among their more intriguing findings, described this week in the journal Science: Various anti-inflammatory agents in the immune system, long known to induce sleep during infection, may also shape normal sleep/wake cycles.

The new research identifies several compounds with surprising effects on sleep and wakefulness in zebrafish. But it also suggests that despite the evolutionary gap between them, zebrafish and mammals may be strikingly similar in the neurochemistry underlying their rest/wake cycles, meaning these same compounds may prove effective in people.

"Many current drug discovery efforts rely on screening conducted outside the body," says Alexander F. Schier, professor of molecular and cellular biology at Harvard. "Although such screens can be successful, they cannot recreate the complex neuroscience of entire organisms. These limitations are particularly acute for behavior-altering drugs because brain activity cannot be modeled in a Petri dish or test tube."

Together with postdoctoral fellows Jason Rihel and David Prober, Schier and other collaborators used their automated screening technique to monitor zebrafish sleep and wakefulness for two days following administration of some 5,600 compounds, creating more than 60,000 distinct behavioral profiles. By applying clustering algorithms to organize these molecules, the researchers identified 463 drug candidates that significantly altered rest and wakefulness, many of which had not previously been known to have such effects.

"For instance, we found that a diverse set of anti-inflammatory compounds increased wakefulness during the day, with much less effect at night," Schier says. "Although these compounds have long been known to promote sleep during infection, this is an indication that the molecules that regulate the immune system may also play a role in setting normal daytime activity levels."

Anti-inflammatory agents found to affect sleep/wake cycles included cytokines, non-steroidal anti-inflammatory drugs (NSAIDs), and the immunosuppressant cyclosporine. Schier and colleagues also found calcium channel inhibitors that increased rest with minimal effects on waking behavior and a class of potassium channel blockers found in a wide variety of drugs -- including antimalarials, antipsychotics, and antihistamines -- that selectively increased wakefulness at night without affecting total rest.

"Behavioral profiling reveals nuanced relationships between drugs and their targets," Schier says. "It can characterize large classes of compounds and reveal differences in effectiveness, potential side effects, and combinatorial properties that might not otherwise be detected."

Schier and his colleagues plan to expand their zebrafish screening to include many more uncharacterized compounds and to assay behaviors that, in humans, are associated with psychiatric disorders.

Schier's co-authors on the Science paper are Jason Rihel, David A. Prober, Anthony Arvanites, Kelvin Lam, Steven Zimmerman, Sumin Jang, and Lee L. Rubin, all at Harvard; Stephen J. Haggerty of the Broad Institute of MIT and Harvard and Massachusetts General Hospital; David Kokel of Massachusetts General Hospital; and Randall T. Peterson of the Broad Institute, Massachusetts General Hospital, and Harvard Medical School.

The work was funded by the Life Sciences Research Foundation, the Helen Hay Whitney Foundation, the National Institutes of Health, the Stanley Medical Research Institute, the Harvard Stem Cell Institute, and the McKnight Endowment Fund for Neuroscience.


Story Source:

The above story is based on materials provided by Harvard University. Note: Materials may be edited for content and length.


Cite This Page:

Harvard University. "New technique uses zebrafish behavior to screen for useful compounds: Pathways affecting sleep and wakefulness discovered." ScienceDaily. ScienceDaily, 15 January 2010. <www.sciencedaily.com/releases/2010/01/100114143018.htm>.
Harvard University. (2010, January 15). New technique uses zebrafish behavior to screen for useful compounds: Pathways affecting sleep and wakefulness discovered. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/01/100114143018.htm
Harvard University. "New technique uses zebrafish behavior to screen for useful compounds: Pathways affecting sleep and wakefulness discovered." ScienceDaily. www.sciencedaily.com/releases/2010/01/100114143018.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins